Clinical Trial Update: Combination of Cryosurgey and NK Immunotherapy for Recurrent Tongue Cancer [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluating the combination of cryosurgery and NK cell immunotherapy for recurrent tongue cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tongue Cancer

Drugs mentioned

• Cryosurgery
• NK immunotherapy (natural killer cell-based immunotherapy)

Snippet

Sponsor: Fuda Cancer Hospital, Guangzhou | Conditions: Recurrent Tongue Cancer | Phase 1, Phase 2 | Status: COMPLETED